Studies in transgenic medaka have shown that expression of Xmrk is correlated with STAT5 activation and increased expression of microphthalmia-associated transcription factor (MITF), which upregulates B-cell lymphoma 2 (Bcl-2) and surviving, and is also associated with melanoma progression [58]. Here, BCL2 is linked to melanoma.